
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epigenetic inhibition assisted chemotherapeutic treatment of lung cancer based on artificial exosomes
Yinshan Lin, Songpei Li, Zekuan Xiao, et al.
Pharmacological Research (2021) Vol. 171, pp. 105787-105787
Closed Access | Times Cited: 25
Yinshan Lin, Songpei Li, Zekuan Xiao, et al.
Pharmacological Research (2021) Vol. 171, pp. 105787-105787
Closed Access | Times Cited: 25
Showing 25 citing articles:
Advances and challenges in the treatment of lung cancer
Yuting Li, Bingshuo Yan, Shiming He
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115891-115891
Open Access | Times Cited: 144
Yuting Li, Bingshuo Yan, Shiming He
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115891-115891
Open Access | Times Cited: 144
Emerging Epigenetic‐Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment
Jiaxin Zhang, Leaf Huang, Guangbo Ge, et al.
Advanced Science (2023) Vol. 10, Iss. 7
Open Access | Times Cited: 27
Jiaxin Zhang, Leaf Huang, Guangbo Ge, et al.
Advanced Science (2023) Vol. 10, Iss. 7
Open Access | Times Cited: 27
The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy
Liang Lu, Huiyu Cen, Jionghua Huang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 37
Liang Lu, Huiyu Cen, Jionghua Huang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 37
Extracellular vesicles as modifiers of epigenomic profiles
Haifeng Zhou, Sheng Hu, Wei Yan
Trends in Genetics (2024) Vol. 40, Iss. 9, pp. 797-809
Closed Access | Times Cited: 7
Haifeng Zhou, Sheng Hu, Wei Yan
Trends in Genetics (2024) Vol. 40, Iss. 9, pp. 797-809
Closed Access | Times Cited: 7
Novel Technologies for Exosome and Exosome-like Nanovesicle Procurement and Enhancement
Andrés Martínez-Santillán, José González‐Valdez
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1487-1487
Open Access | Times Cited: 13
Andrés Martínez-Santillán, José González‐Valdez
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1487-1487
Open Access | Times Cited: 13
Biomedical applications of artificial exosomes for intranasal drug delivery
Jinming Zhao, Jingxing Yang, Jian Jiao, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 13
Jinming Zhao, Jingxing Yang, Jian Jiao, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 13
Smart Lipid‐Based Nanoparticles in Lung Cancer Treatment: Current Status and Future Directions
Ramin Yousefpour Shahrivar, Zahra Ahmadi Fakhr, Elham Abbasgholinejad, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 12
Closed Access | Times Cited: 12
Ramin Yousefpour Shahrivar, Zahra Ahmadi Fakhr, Elham Abbasgholinejad, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 12
Closed Access | Times Cited: 12
Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence
Min Deng, Shuang Wu, Peizheng Huang, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 6, pp. 100870-100870
Open Access | Times Cited: 12
Min Deng, Shuang Wu, Peizheng Huang, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 6, pp. 100870-100870
Open Access | Times Cited: 12
Progress in extracellular vesicle@STING towards immune regulation
Xinyi Wang, Iek Man Lei, Bei Li, et al.
Chinese Chemical Letters (2025), pp. 110990-110990
Closed Access
Xinyi Wang, Iek Man Lei, Bei Li, et al.
Chinese Chemical Letters (2025), pp. 110990-110990
Closed Access
Therapeutic regulation of epigenetics in cancer treatment through drug delivery systems
Boyu Su, Shangkuo Li, Shuo Geng, et al.
Nano Today (2024) Vol. 56, pp. 102251-102251
Closed Access | Times Cited: 3
Boyu Su, Shangkuo Li, Shuo Geng, et al.
Nano Today (2024) Vol. 56, pp. 102251-102251
Closed Access | Times Cited: 3
Targeting the epigenome with advanced delivery strategies for epigenetic modulators
Sonia Guha, Yogeswaran Jagadeesan, Murali Monohar Pandey, et al.
Bioengineering & Translational Medicine (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Sonia Guha, Yogeswaran Jagadeesan, Murali Monohar Pandey, et al.
Bioengineering & Translational Medicine (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Bioinspired PROTAC-induced macrophage fate determination alleviates atherosclerosis
Jionghua Huang, Chuang-jia Huang, Lina Yu, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 10, pp. 1962-1976
Closed Access | Times Cited: 9
Jionghua Huang, Chuang-jia Huang, Lina Yu, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 10, pp. 1962-1976
Closed Access | Times Cited: 9
Biomimetic metal–organic frameworks navigated biological bombs for efficient lung cancer therapy
Langyu Yang, Yinshan Lin, Jian Zhang, et al.
Journal of Colloid and Interface Science (2022) Vol. 625, pp. 532-543
Closed Access | Times Cited: 14
Langyu Yang, Yinshan Lin, Jian Zhang, et al.
Journal of Colloid and Interface Science (2022) Vol. 625, pp. 532-543
Closed Access | Times Cited: 14
Magnetically controlled nanorobots induced oriented and rapid clearance of the cytokine storm for acute lung injury therapy
Sheng Chen, Enen Chen, Xiaoling Guan, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 234, pp. 113731-113731
Closed Access | Times Cited: 7
Sheng Chen, Enen Chen, Xiaoling Guan, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 234, pp. 113731-113731
Closed Access | Times Cited: 7
Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death
Yawen Guo, Ruijie Qian, Zijie Li, et al.
Life Sciences (2024) Vol. 348, pp. 122687-122687
Closed Access | Times Cited: 2
Yawen Guo, Ruijie Qian, Zijie Li, et al.
Life Sciences (2024) Vol. 348, pp. 122687-122687
Closed Access | Times Cited: 2
Artificial stem cells mediated inflammation-tropic delivery of antiviral drugs for pneumonia treatment
Aiping Qin, Sheng Chen, Songpei Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Aiping Qin, Sheng Chen, Songpei Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Cell Membrane-Camouflaged Nanoparticles Mediated Nucleic Acids Delivery
Yinshan Lin, Xiaoling Guan, Jianfen Su, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 8001-8021
Open Access | Times Cited: 5
Yinshan Lin, Xiaoling Guan, Jianfen Su, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 8001-8021
Open Access | Times Cited: 5
EV-out or EV-in: Tackling cell-to-cell communication within the tumor microenvironment to enhance anti-tumor efficacy using extracellular vesicle-based therapeutic strategies
Wararat Chiangjong, Somchai Chutipongtanate
OpenNano (2022) Vol. 8, pp. 100085-100085
Open Access | Times Cited: 8
Wararat Chiangjong, Somchai Chutipongtanate
OpenNano (2022) Vol. 8, pp. 100085-100085
Open Access | Times Cited: 8
Advances in Exosome Research in the Management of Lung Cancer
Huiqing Shen, Dawei Cao, Xinri Zhang
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 10, pp. 921-930
Closed Access | Times Cited: 4
Huiqing Shen, Dawei Cao, Xinri Zhang
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 10, pp. 921-930
Closed Access | Times Cited: 4
Development of an Organ-Directed Exosome-Based siRNA-Carrier Derived from Autologous Serum for Lung Metastases and Testing in the B16/BL6 Spontaneous Lung Metastasis Model
Mai Hazekawa, Takuya Nishinakagawa, Masato Hosokawa, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 815-815
Open Access | Times Cited: 6
Mai Hazekawa, Takuya Nishinakagawa, Masato Hosokawa, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 815-815
Open Access | Times Cited: 6
Evaluation of the Therapeutic Potential of Histone Deacetylase 6 Inhibitors for Primary and Metastatic Uveal Melanoma
Husvinee Sundaramurthi, Zoltán Giricz, Breandán N. Kennedy
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9378-9378
Open Access | Times Cited: 4
Husvinee Sundaramurthi, Zoltán Giricz, Breandán N. Kennedy
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9378-9378
Open Access | Times Cited: 4
Efficient Photoacoustic Imaging With Biomimetic Mesoporous Silica-Based Nanoparticles
Chuangjia Huang, Xiaoling Guan, Hui Lin, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 4
Chuangjia Huang, Xiaoling Guan, Hui Lin, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 4
Bioinspired black phosphorus delivers histone deacetylase inhibitor-induced synergistic therapy for lung cancer
Huan Li, Xiaoling Guan, Songpei Li, et al.
Journal of Colloid and Interface Science (2024) Vol. 680, pp. 298-310
Closed Access
Huan Li, Xiaoling Guan, Songpei Li, et al.
Journal of Colloid and Interface Science (2024) Vol. 680, pp. 298-310
Closed Access
Perspectives on materials: Reality and potential of epigenetic drug nano-delivery
Yunxiang Zhang, Derui Xu, Xianglin Hou, et al.
Chemical Engineering Journal (2024), pp. 157746-157746
Closed Access
Yunxiang Zhang, Derui Xu, Xianglin Hou, et al.
Chemical Engineering Journal (2024), pp. 157746-157746
Closed Access
Biomedical Applications of Extracellular Vesicles in Treatment of Disease
Fei Wang, Jiacong Ai, Ziyang Zhang, et al.
(2023), pp. 59-99
Closed Access
Fei Wang, Jiacong Ai, Ziyang Zhang, et al.
(2023), pp. 59-99
Closed Access